EN
VN

VINBRAIN COOPERATES WITH THE NATIONAL INSTITUTE OF HEMATOLOGY AND BLOOD TRANSFUSION TO APPLY ARTIFICIAL INTELLIGENCE (AI) TO THE SCREENING, DIAGNOSIS, TREATMENT AND PREVENTION OF HEMATOLOGICAL DISEASES

Calendar 04/07/2021

Congenital hemolytic disease (also known as thalassemia) is a common inherited blood disease in the world and in Vietnam. The disease is characterized by profuse hemolysis and often leads to chronic anemia. Patients must maintain the long-term treatment process, consuming material and spiritual. Children with severe illness often have delayed physical development and delayed puberty. Although the disease is dangerous, it can be actively prevented through screening tests, detecting disease genes at the pre-marital stage and prenatal diagnosis.

Since 2019, Vingroup's Thien Tam Fund has cooperated with Thalassemia Center (under the Central Institute of Hematology and Blood Transfusion) to implement a free screening program for hemolytic anemia for people. counseling and guiding preventive measures for people carrying disease genes with the goal of not having children with the disease.

In an effort to join hands to reverse congenital hemolytic disease, Thien Tam Foundation consulted and connected the National Institute of Hematology and Blood Transfusion with VinBrain to deploy a project to apply artificial intelligence (AI) to screening and treatment. prevent congenital hemolytic disease.

Accordingly, on March 15, 2021, VinBrain officially signed a cooperation agreement (MoA) with the National Institute of Hematology and Blood Transfusion in the application of artificial intelligence (AI) to support screening and diagnosis. Diagnosis, treatment and prevention of hematological diseases.

Speaking at the Signing Ceremony, Dr. Bach Quoc Khanh – Director said: “I am very touched and appreciate the opportunity to cooperate with VinBrain Co., Ltd – Vingroup in projects for public health. I hope and believe that this cooperation will be successful and bring many benefits to the community.”

Dr. Bach Quoc Khanh - Director of the National Institute of Hematology - Blood Transfusion discussed with Mr. Truong Quoc Hung - CEO of VinBrain about current diagnostic and screening methods for hematological diseases

Also on this occasion, VinBrain team visited and donated children's books and toys to children with hemophilia being treated at the Institute's Thalassemia Center. With this visit, VinBrain team wishes to share the pain of the pediatric patients as well as the difficulties of their families. From there, spread love and encourage children and their families to persevere through the disease.

 

Share:

News Related

Calendar 12/08/2022

VinBrain - Medtech solution for a better healthcare

Within the framework of the Forbes Impact Business Summit organized by Forbes Vietnam and LIN...
View More
HEALTH HACKATHON 2022 - CEO VINBRAIN VỚI CHỦ ĐỀ SỐ HÓA TRONG Y TẾ Calendar 08/08/2022

Health Hackathon 2022 - CEO VinBrain with "Digitalization in health"

At Health Hackathon 2022, CEO of VinBrain made views on "Digitalization in healthcare"
View More
Calendar 08/08/2022

VinBrain: Những bộ óc Việt và hành trình mang AI tới thế giới

Có chung đam mê với trí tuệ nhân tạo (AI), những bộ óc Việt tại...
View More
VINBRAIN - DRAID™ MANG CÔNG NGHỆ CHẨN ĐOÁN Y TẾ AI CHO HÀNG TỶ NGƯỜI Calendar 05/08/2022

DrAid™ - Công nghệ chẩn đoán y tế AI của Việt Nam có cơ hội được ứng dụng toàn cầu

Nếu vượt qua những bài kiểm tra khắt khe từ FINDDX, WHO sẽ chứng thực...
View More
FORBES 2022: VINBRAIN AND FUTURE SOLUTIONS FOR VIETNAMESE HEALTHCARE INDUSTRY Calendar 03/08/2022

Forbes 2022: VinBrain and future solutions for vietnamese healthcare industry

In August, VinBrain CEO - Mr. Truong Quoc Hung is going to be invited to...
View More
DRAID x FERRUM VÀ SỨ MỆNH GIÚP 7 TRIỆU BỆNH NHÂN Calendar 27/07/2022

DrAid™ x Ferrum with mission of helping 7M patients

Ferrum Health, the industry leader in enterprise AI solutions for global health systems, announces that...
View More

Top

Share